EuroGenerics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEuroGenerics

EuroGenerics

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Qutavina	Teriparatide	2020-08-27	2025	Osteoporosis , Postmenopausal osteoporosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

chronic obstructive pulmonary disease

,

pneumococcal pneumonia

,

haemophilus influenzae

,

streptococcus pneumoniae

,

,

respiratory tract diseases

,

respiration disorders

,

,

neisseria meningitidis

,

,

respiratory syncytial virus infections

,

influenza in birds

,

,

,

,

,

,

,

,

,

meningococcal infections

,

human influenza

,

h1n1 subtype influenza a virus

,

haemophilus influenzae type b

,

,

,

healthy volunteers/patients

,

,

,

respiratory tract infections

,

communicable diseases

,

disease progression

,

,

,

,

bronchial spasm

,

multiple sclerosis

,

,

,

,

,

infectious encephalitis

,

immunologic tests

,

,

,

pneumococcal infections

,

,

,

drug-related side effects and adverse reactions

paramyxoviridae infections

,

influenza in birds

,

,

multiple sclerosis

,

,

,

,

,

orthomyxoviridae

,

,

communicable diseases

,

infectious myxomatosis

,

h1n1 subtype influenza a virus

,

,

,

,

,

viral hemorrhagic fevers

,

,

,

,

,

,

,

meningococcal infections

,

,

haemophilus influenzae type b

,

inactivated vaccines

,

,

human influenza

,

orthomyxoviridae infections

,

healthy volunteers/patients

,

,

,

myocardial infarction

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

,

immune system diseases

,

pregnancy complications

,

,

toxicological phenomena

,

,

respiratory syncytial virus infections

,

,

,

,

atrial fibrillation

,

cardiovascular diseases

,

coronary disease

,

cardiac arrhythmias

,

,

,

diabetes mellitus

,

respiratory tract infections

,

inferior wall myocardial infarction

,

severe acute respiratory syndrome

,

behavior and behavior mechanisms

,

paramyxoviridae infections

,

influenza in birds

,

,

multiple sclerosis

,

,

,

,

,

orthomyxoviridae

,

,

communicable diseases

,

infectious myxomatosis

,

h1n1 subtype influenza a virus

,

,

,

,

,

viral hemorrhagic fevers

,

,

,

,

,

,

,

meningococcal infections

,

,

haemophilus influenzae type b

,

inactivated vaccines

,

,

human influenza

,

orthomyxoviridae infections

,

healthy volunteers/patients

,

,

,

myocardial infarction

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

,

immune system diseases

,

pregnancy complications

,

,

toxicological phenomena

,

,

respiratory syncytial virus infections

,

,

,

,

atrial fibrillation

,

cardiovascular diseases

,

coronary disease

,

cardiac arrhythmias

,

,

,

diabetes mellitus

,

respiratory tract infections

,

inferior wall myocardial infarction

,

severe acute respiratory syndrome

,

behavior and behavior mechanisms

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use